Radionuclide Therapies(RNTs):Radiation protection issues for the caregivers

来源 :The 15th Asia-Oceania Congress of Medical Physics (AOCMP2015 | 被引量 : 0次 | 上传用户:cxdong54321
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Purpose:Radionuclide therapies(RNTs)have been proved to be beneficial with respect to tumour response and in improving patients quality of life.Radiation protection issues have been raised regarding patients caregivers and public,and restrictions have been proposed and applied to reduce the radiation exposure to these groups.The aim of this study is to systematically review the literature pertaining to radiation exposure of caregivers of patients undergoing RNTs.Methods:This work included studies published from 1999 to 2014.Papers with dose measurements of caregivers for various types of RNTs were included.In these papers,measurements were performed by utilizing various types of dosimeters.Papers with either outpatient administrations or inpatient procedures were included.Data were classified according to the applied RNT protocol.Protocol parameters included the type of RNT,the radionuclide used,the applied protocol of dose measurement,the level of administered radioactivity,the type of dosimeter,the study duration,the study sample and the radiation protection instructions.Results:Twenty papers in total were included in the study.Among them 10 concerned thyroid cancer,4 Β-cell lymphoma,3 thyrotoxicosis(hyperthyroidism),1 both thyroid cancer and thyrotoxicosis,1 pediatric neuroblastoma,and 1 NETs.In the examined papers,the average recorded doses of caregivers were found to be much lower than the corresponding dose constraint.Coclusions:In conclusion,when adequate radiation protection instructions are provided under the supervision and guidance of experts,the dose to the caregivers can be maintained at very low levels.With regard to specifying the appropriate patient discharge strategy and length of possibly required hospitalisation,it is recommended that new criteria,in addition to accounting for the level of residual activity,should be adopted.These criteria should take into account the patients lifestyle and socioeconomic conditions and their ability to comply with the radiation protection instructions.
其他文献
The objective of this study was to determine T2 relaxation times in high-fat(HF)diet-induced fatty liver in rats using localized point-resolved spectroscopy sequence(PRESS).The examinations were perfo
Background and purpose: Methamphetamine(MA)is a highly addictive stimulant that affects to neurotoxicity of the brain.Changes of brain metabolites and brain volume in MA abusers have been documented.H
Purpose:To measure the output factor(OF) from very small stereotactic circular cones using various active and passive detectors following different protocols.
会议
Introduction: Over the last 20 years Interventional cardiology has expanded significantly,both in the field of diagnosis and therapy.These intervention procedures are performed under fluoroscopic guid
Purpose: Reflective-type radiochromic film(GAFCHROMCI RTQA2)is one of the most useful devices for quality assurance of radiotherapy equipment.The aim of this study is to investigate the dosimetric unc
Introduction:There are various low-level radioactive contamination areas in some part of eastern Japan and RI facilities.Radiation exposure from gamma-rays emitted in these contamination areas is one
Purpose:The purpose of the present thesis was to study the effect of the 3D printed bolus in intensity-modulated radiation therapy of nasal cavity tumor.Methods:A uniform 1cm thickness 3D bolus was de
会议
Purpose:To calculate the organ dose conversion coefficients for external photon irradiation of Chinese adult male with different body size.
会议
Purpose:The purpose of this paper is to study the MLC leakage radiation between two rows of blades and between adjacent blades of 6 MV-X Flatting Filter Free(FFF)beam and Flatting Filter beam(FF)of th
Purpose Peptide Receptor Radionuclide Therapy(PRRT) is a well-established treatment option for inoperable or metastasised NeuroEndocrine Tumours(NETs).